Top Safety Accreditation for Extract Technology Ltd
International business Extract Technology has been awarded accreditation from Safecontractor for its commitment to achieving excellence in health and safety.
Safecontractor is a leading third party accreditation scheme which recognises very high standards in health and safety management amongst UK companies.
Employing 65 people in Huddersfield, Extract Technology is principally involved in the life science sector, specialising in the containment and aseptic solutions for the pharmaceutical and biotech industries. Extract Technology’s most recent clients have included major players such as GlaxoSmithKline, Astra Zeneca, TEVA and Sandoz.
The company’s application for Safecontractor accreditation was driven by the need for a uniform standard across the business.
General Manager Alan Wainwright commented: “I would like to thank all those involved for their hard work in helping to achieve the standard. To gain accreditation to the scheme is another important achievement for our business and clearly demonstrates our commitment to health and safety within our organisation. Safecontractor accreditation not only supports our overall health and safety management practices but will enhance the company’s ability to attract new contracts.”
John Kinge, Technical Director of Safecontractor said: "Major organisations simply cannot afford to run the risk of employing contractors who are not able to prove that they have sound health and safety policies in place."
"More companies need to understand the importance of adopting good risk management in the way that Extract Technology has done. The firm’s high standard has set an example which hopefully will be followed by other companies within the sector.
Safecontractor plays a vital role in supporting our clients in meeting their compliance needs, whilst working with their contractors as they progress through the accreditation process.”
Under the Safecontractor scheme, businesses undergo a vetting process which examines health and safety procedures and their track record for safe practice. Those companies meeting the high standard are included on a database, which is accessible to registered users only via a website.
Client-organisations who sign up to the scheme can access the database, enabling them to audit potential contractors before they attend site. These clients agree that, as users of the scheme, they will engage only those who have received accreditation.
Over 210 major, nation-wide businesses, from several key sectors, have signed up to use the scheme when selecting contractors for services such as building, cleaning, maintenance, refurbishment or electrical and mechanical work.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.